BIOMET BC R 1X40 US
Report
- Report Number
- 3006946279-2024-00031
- Event Type
- Injury
- Date Received
- June 17, 2024
- Date of Event
- September 8, 2023
- Report Date
- July 11, 2024
- Manufacturer
- BIOMET FRANCE S.A.R.L.
- Product Code
- LOD
- UDI-DI
- 00887868214578
- PMA / PMN Number
- K172408
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CO, US
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
(B)(4). THIS FOLLOW-UP REPORT IS BEING SUBMITTED TO RELAY ADDITIONAL AND/OR CORRECTED INFORMATION. . ARTHROFIBROSIS IS DEFINED AS THE DEVELOPMENT OF FIBROUS SCAR TISSUE WITHIN OR SURROUNDING A JOINT. ARTHROFIBROSIS IS A KNOWN POSTOPERATIVE PROCEDURE RELATED COMPLICATION THAT CAN OCCUR FROM SURGICAL IMPLANTATION OF NEW JOINT REPLACEMENT AS WELL AS FROM PREVIOUS INJURIES OR SURGICAL PROCEDURES. SCAR TISSUE FORMATION IS A NORMAL HEALING RESPONSE; HOWEVER, THE BUILDUP OF SUCH CAN RESULT IN PAIN, STIFFNESS, LIMITED RANGE OF MOTION, AND DIFFICULTY PROPERLY AMBULATING. IF EXCESS SCAR TISSUE DEVELOPS, CONSERVATIVE MEASURES SUCH AS EXERCISES OR PHYSICAL THERAPY WOULD BE ATTEMPTED FIRST. IF THESE ATTEMPTS FAIL, SURGICAL INTERVENTION SUCH AS MANIPULATION UNDER ANESTHESIA, ARTHROSCOPIC ARTHROLYSIS, OR OPEN ARTHROTOMY WOULD BECOME NECESSARY TO REMOVE THE FIBROUS TISSUE AND RESTORE JOINT FUNCTION. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL REPORT WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS.
(B)(4) D10: ITEM #42-5028-060-01; LOT #65561098; FEMUR TRABECULAR METAL CRUCIATE RETAINING (CR) STANDARD POROUS. ITEM #00-5954-037-01; LOT #64648962; TIBIAL TRAY FIXED BEARING SIZE 3 DO NOT USE WITH ARTICULAR SURFACE THICKNESSES GREATER THAN 17 MM. ITEM #00-5952-030-14; LOT #64753797; ARTICULAR SURFACE USE WITH PLATE 3,4 SIZE YELLOW/C-H 14 MM HEIGHT. ITEM #00-5972-065-32; LOT #65937727; ALL POLY PETELLA STANDARD CEMENTED SIZE 32 MM DIAMETER 8.5 MM THICKNESS. THE DEVICE WILL NOT BE RETURNED FOR ANALYSIS; HOWEVER, AN INVESTIGATION OF THE REPORTED EVENT IS IN PROGRESS. ONCE THE INVESTIGATION IS COMPLETED, A SUPPLEMENTAL MEDWATCH 3500A WILL BE SUBMITTED.
NO FURTHER EVENT INFORMATION AVAILABLE AT THE TIME OF THIS REPORT.
IT WAS REPORTED PATIENT UNDERWENT MANIPULATION UNDER ANESTHESIA DUE TO STIFFNESS AND ARTHROFIBROSIS POST IMPLANTATION. DURING THE PROCEDURE THE SURGEON WAS ABLE TO BREAK UP ADHESIONS AND SCAR TISSUE INCREASING RANGE OF MOTION. ATTEMPTS HAVE BEEN MADE AND NO FURTHER INFORMATION HAS BEEN PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2310902 | BIOMET BC R 1X40 US | BIOMET BONE CEMENT R | LOD | BIOMET FRANCE S.A.R.L. | N/A | AX46BI1606 | 00887868214578 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Female | Hospitalization| R | SEE H10 NARRATIVE |